Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 10, 2010, Pages 706-712

  Huhn, R ^a   Heinen, A ^a   Hollmann, M W ^a   Schlack, W ^a   Preckel, B ^a   Weber, N C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Diabetes; Ischaemia; MPTP; Postconditioning; Sevoflurane

Indexed keywords

CARRIER PROTEIN; CYCLOSPORIN; ETHER DERIVATIVE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; SEVOFLURANE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HEMODYNAMICS; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC POSTCONDITIONING; MALE; METABOLOME; OBESITY; PATHOLOGY; RAT; REPERFUSION INJURY; ZUCKER RAT;

ANIMALS; BLOOD GLUCOSE; CYCLOSPORINE; HEMODYNAMICS; ISCHEMIC POSTCONDITIONING; MALE; METABOLOME; METHYL ETHERS; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OBESITY; PREDIABETIC STATE; RATS; RATS, ZUCKER;

ANIMALIA; RATTUS;

EID: 78649751904     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.06.010     Document Type: Article

References (28)

1. Preckel B., Schlack W., Comfere T., Obal D., Barthel H., Thamer V. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br J Anaesth 1998, 81:905-912.
2. Chiari P.C., Bienengraeber M.W., Pagel P.S., Krolikowski J.G., Kersten J.R., Warltier D.C. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005, 102:102-109.
3. Deyhimy D.I., Fleming N.W., Brodkin I.G., Liu H. Anesthetic preconditioning combined with postconditioning offers no additional benefit over preconditioning or postconditioning alone. Anesth Analg 2007, 105:316-324.
4. Obal D., Dettwiler S., Favoccia C., Scharbatke H., Preckel B., Schlack W. The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg 2005, 101:1252-1260.
5. Obal D., Preckel B., Scharbatke H., Mullenheim J., Hoterkes F., Thamer V., et al. One MAC of sevoflurane provides protection against reperfusion injury in the rat heart in vivo. Br J Anaesth 2001, 87:905-911.
6. Kehl F., Krolikowski J.G., Mraovic B., Pagel P.S., Warltier D.C., Kersten J.R. Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology 2002, 96:183-188.
7. Kersten J.R., Schmeling T.J., Orth K.G., Pagel P.S., Warltier D.C. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol 1998, 275:H721-H725.
8. Ebel D., Mullenheim J., Frassdorf J., Heinen A., Huhn R., Bohlen T., et al. Effect of acute hyperglycaemia and diabetes mellitus with and without short-term insulin treatment on myocardial ischaemic late preconditioning in the rabbit heart in vivo. Pflugers Arch 2003, 446:175-182.
9. Gross E.R., Hsu A.K., Gross G.J. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3{beta}. Diabetes 2007, 56:127-136.
10. Huhn R., Heinen A., Weber N.C., Hollmann M.W., Schlack W., Preckel B. Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth 2008, 100:465-471.
11. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999, 341(Pt 2):233-249.
12. Hausenloy D.J., Maddock H.L., Baxter G.F., Yellon D.M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc Res 2002, 55:534-543.
13. Katakam P.V., Jordan J.E., Snipes J.A., Tulbert C.D., Miller A.W., Busija D.W. Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance. Am J Physiol Regul Integr Comp Physiol 2007, 292:R920-R926.
14. Frangioudakis G., Cooney G.J. Acute elevation of circulating fatty acids impairs downstream insulin signalling in rat skeletal muscle in vivo independent of effects on stress signalling. J Endocrinol 2008, 197:277-285.
15. Gomez L., Paillard M., Thibault H., Derumeaux G., Ovize M. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008, 117:2761-2768.
16. Kristiansen S.B., Lofgren B., Stottrup N.B., Khatir D., Nielsen-Kudsk J.E., Nielsen T.T., et al. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 2004, 47:1716-1721.
17. Tsang A., Hausenloy D.J., Mocanu M.M., Carr R.D., Yellon D.M. Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes 2005, 54:2360-2364.
18. Halestrap A.P., Clarke S.J., Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 2004, 61:372-385.
19. Kim J.A., Montagnani M., Koh K.K., Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006, 113:1888-1904.
20. Halestrap A.P., Clarke S.J., Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 2007, 1767:1007-1031.
21. Nishihara M., Miura T., Miki T., Tanno M., Yano T., Naitoh K., et al. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 2007, 43:564-570.
22. Huhn R., Heinen A., Weber N.C., Kerindongo R.P., Oei G.T., Hollmann M.W., et al. Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo. J Pharmacol Exp Ther 2009, 329:600-607.
23. Iliodromitis E.K., Zoga A., Vrettou A., Andreadou I., Paraskevaidis I.A., Kaklamanis L., et al. The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits. Atherosclerosis 2006, 188:356-362.
24. Kupai K., Csonka C., Bencsik P.F.G., Csont T., Ferdinandy P. The cardioprotective effect of postconditioning is lost in cholesterol diet-induced hyperlipidemia in rats. J Mol Cell Cardiol 2006, 40:976-977. [abstract].
25. Ferdinandy P., Szilvassy Z., Horvath L.I., Csont T., Csonka C., Nagy E., et al. Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardiol 1997, 29:3321-3333.
26. Ueda Y., Kitakaze M., Komamura K., Minamino T., Asanuma H., Sato H., et al. Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction. J Am Coll Cardiol 1999, 34:2120-2125.
27. Juhasz B., Der P., Turoczi T., Bacskay I., Varga E., Tosaki A. Preconditioning in intact and previously diseased myocardium: laboratory or clinical dilemma?. Antioxid Redox Signal 2004, 6:325-333.
28. Wagner C., Kloeting I., Strasser R.H., Weinbrenner C. Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta. J Cardiovasc Pharmacol 2008, 52:430-437.